Pharmaceutical
August 9, 2010
U.S. drug maker Merck & Co. said it has received letters from the federal government seeking information about its activities in foreign countries, in connection with a U.S. anti-foreign bribery
Read More
August 2, 2010
According to the Boston Herald, Charles River Laboratories has withdrew a $1.6 billion bid for WuXi PharmaTech, citing investor opposition to what would have been the largest foreign takeover of
Read More
July 12, 2010
Xcelience LLc will expand its pharmaceutical manufacturing to Europe as part of a joint venture agreement with Penn Pharma, reports Bizjournal.com. The joint venture provides pharmaceutical and biotechnology companies a
Read More
July 6, 2010
Watson Pharmaceuticals Inc. completed its acquisition of the U.S. rights to a Columbia Laboratories'' progesterone drug in a deal that could be worth more than $92.5 million reports the Associated
Read More
June 21, 2010
A drug manufactured from cannabis went on sale in the U.K. as a treatment for symptoms of multiple sclerosis. Sativex, which is made from cannabis plants grown at secret
Read More
June 14, 2010
According to the Associated Press, drug developer Novavax Inc. said its joint venture with an Indian company has finished building a factory in Dholka, India, that will produce flu vaccines.
Read More
June 7, 2010
The Associated Press reports officials have urged Bristol-Myers Squibb not to shut down a plant in France, which makes AIDS drugs, saying the move will jeopardize the lives of thousands
Read More
June 7, 2010
According to PRNewswire, Albemarle Corporation, a global supplier of fine chemistry services for pharmaceutical, agricultural and specialty chemical products, announced it is building a state of the art kilo lab
Read More
May 24, 2010
Abbott Laboratories has agreed to buy the domestic healthcare business of India''s Piramal Healthcare Ltd., a leading branded generics company, for $3.72 billion, the companies announced last week reports
Read More
May 17, 2010
The Associated Press reports Japanese drug maker, Astellas Pharma Inc., said it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to
Read More